Bg pattern

DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Desloratadine STADA 0.5 mg/ml Oral Solution EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Desloratadine STADA and what is it used for
  1. What you need to know before you take Desloratadine STADA
  2. How to take Desloratadine STADA
  3. Possible side effects
  1. Storage of Desloratadine STADA

Contents of the pack and additional information

1. What is Desloratadine STADA and what is it used for

What is Desloratadine STADA

Desloratadine STADA contains desloratadine, which is an antihistamine.

How Desloratadine STADA works

Desloratadine STADA oral solution is an anti-allergic medicine that does not cause drowsiness. It helps to control the allergic reaction and its symptoms.

When to use Desloratadine STADA

Desloratadine STADA oral solution relieves the symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or house dust mite allergy) in adults, adolescents, and children from 1 year of age. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red, or watery eyes.

Desloratadine STADA oral solution is also used to relieve the symptoms associated with urticaria (a skin disease caused by an allergy). These symptoms include itching and skin rash.

Relief of these symptoms lasts a full day and helps you to continue your daily activities and normal sleep periods.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Desloratadine STADA

Do not take Desloratadine STADA

  • if you are allergic to desloratadine or any of the other ingredients of this medicine (listed in section 6) or to loratadine.

Warnings and precautions

Consult your doctor or pharmacist before taking Desloratadine STADA.

  • if you have impaired kidney function.
  • if you have a personal or family history of seizures.

Use in children and adolescents

Do not give this medicine to children under 1 year of age.

Other medicines and Desloratadine STADA

Hypodermic needle inserted into the skin at a 45-degree angle showing subcutaneous and muscular tissueThere are no known interactions of Desloratadine STADA with other medicines.

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Desloratadine STADA with food, drinks, and alcohol

Desloratadine STADA can be taken with or without food.

Be careful when taking Desloratadine STADA with alcohol.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

It is not recommended to take Desloratadine STADA oral solution if you are pregnant or breastfeeding.

Fertility

There are no data available on male and female fertility.

Driving and using machines

At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. Although most people do not experience drowsiness, it is recommended not to engage in activities that require a state of alertness, such as driving a car or using machines, until you have determined your own response to the medicine.

Desloratadine STADA contains sorbitol

This medicine contains 103 mg of sorbitol per ml.

Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the patient cannot break down fructose, consult your doctor before taking this medicine.

Desloratadine STADA contains propylene glycol

This medicine contains 102.3 mg of propylene glycol per ml.

Desloratadine STADA contains sodium

This medicine contains 3.854 mg of sodium (main component of table salt/cooking salt) per ml. This is equivalent to 38.54 mg of sodium in a 10 ml dose, which is equivalent to 1.927% of the maximum recommended daily intake of sodium for an adult.

3. How to take Desloratadine STADA

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Children

Children from 1 to 5 years of age:

The recommended dose is 2.5 ml (½ of a 5 ml spoon) of oral solution once a day.

Children from 6 to 11 years of age:

The recommended dose is 5 ml (one 5 ml spoon) of oral solution once a day.

Adults and adolescents from 12 years of age

The recommended dose is 10 ml (two 5 ml spoons) of oral solution once a day.

In case the package containing the bottle of oral solution includes a dosing syringe, you can use it as an alternative to take the appropriate amount of oral solution.

Method of administration

This medicine is for oral use.

Swallow the dose of oral solution and then drink a little water. You can take this medicine with or without food.

Duration of treatment

Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you have and how long you should take Desloratadine STADA oral solution.

If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days a week or for less than 4 weeks), your doctor will recommend a treatment schedule that depends on the evaluation of the history of your disease.

If your allergic rhinitis is persistent (presence of symptoms for 4 or more days a week and for more than 4 weeks), your doctor may recommend long-term treatment.

For urticaria, the duration of treatment may vary from patient to patient and therefore you should follow your doctor's instructions.

If you take more Desloratadine STADA than you should

Take Desloratadine STADA oral solution only as your doctor has told you. It is not expected that an accidental overdose will cause serious problems. However, in case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Desloratadine STADA

Hypodermic needle inserted into the skin at an ascending angle and a small amount of liquid coming outIf you forget to take your dose at the right time, take it as soon as possible and then continue with the usual dosing schedule. Do not take a double dose to make up for forgotten doses.

If you stop taking Desloratadine STADA

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

During the marketing of desloratadine, very rare cases of serious allergic reactions (difficulty breathing, wheezing, itching, skin rash, and swelling) have been reported. If you experience any of these serious side effects, stop taking this medicine and go to your doctor immediately.

In clinical trials in most children and adults, the side effects with desloratadine were approximately the same as with a solution or tablet that does not contain the active ingredient. However, the frequent side effects in children under 2 years of age were diarrhea, fever, and insomnia, while in adults, fatigue, dry mouth, and headache were reported more frequently than with a tablet that does not contain the active ingredient.

In clinical trials with desloratadine, the following side effects were reported:

Children

Frequent in children under 2 years of age: the following may affect up to 1 in 10 children

  • diarrhea
  • fever
  • insomnia

Adults

Frequent: the following may affect up to 1 in 10 people

  • fatigue
  • dry mouth
  • headache

During the marketing of desloratadine, the following side effects were reported:

Adults

Very rare: the following may affect up to 1 in 10,000 people

  • serious allergic reactions
  • skin rash
  • strong or irregular heartbeats
  • fast heartbeats
  • stomach pain
  • nausea
  • vomiting
  • upset stomach
  • diarrhea
  • dizziness
  • drowsiness
  • difficulty sleeping
  • muscle pain
  • hallucinations
  • seizures
  • agitation with increased body movement
  • liver inflammation
  • alteration in liver function tests

Frequency not known: frequency cannot be estimated from the available data

  • unusual weakness
  • yellowing of the skin and/or eyes
  • increased sensitivity of the skin to the sun, even on cloudy days, and to ultraviolet light, for example, to the ultraviolet light of a sunbed
  • change in heart rhythm
  • abnormal behavior
  • aggression
  • weight gain, increased appetite
  • depressed mood
  • dry eyes

Children

Frequency not known: frequency cannot be estimated from the available data

  • slow heartbeat
  • change in heart rhythm
  • abnormal behavior
  • aggression
  • weight gain, increased appetite

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system included in the Spanish Medicines and Health Products Surveillance System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Desloratadine STADA

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bottle after EXP. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

Use only during the 2 months following the first opening of the bottle.

Do not use this medicine if you notice any change in the appearance of the oral solution.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and additional information

Composition of Desloratadine STADA

Hypodermic needle inserted into the skin at an ascending angle and a small amount of liquid coming outThe active substance is desloratadine. Each ml of Desloratadine STADA contains 0.5 mg of desloratadine.

The other ingredients of the oral solution are:

Liquid sorbitol (E420) (non-crystallizing)

Propylene glycol

Citric acid monohydrate

Sodium citrate

Hypromellose 2910

Sucralose

Disodium edetate

Tuti fruti flavor

Purified water.

Appearance of the product and contents of the pack

Desloratadine STADA oral solution is presented as a clear, colorless solution, free of foreign substances.

Desloratadine STADA oral solution is presented in six different volume sizes: 50, 60, 100, 120, 150, and 300 ml, packaged in type III amber glass bottles with a child-resistant plastic screw cap, with a multilayer coating of polyethylene or with a child-resistant plastic screw cap consisting of an outer layer and an inner layer of polypropylene and polyethylene, respectively. The bottles are then packaged in cardboard boxes. All presentations include a measuring spoon with marks for 2.5 ml and 5 ml doses or a dosing syringe for oral use with a final volume of 5 ml marked every 0.5 ml.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer Marketing authorization holder

Laboratorio STADA, S.L. Frederic Mompou, 5

08960 Sant Just Desvern (Barcelona) [email protected]

Manufacturer

STADA Arzneimittel AG Stadastrasse 2-18

61118 Bad Vilbel Germany

or

Delpharm Orleans

Hypodermic needle inserted into the skin at an ascending angle and a small red spot around the injection site5 avenue de Concyr

45071 Orleans CEDEX 2 France

or

Balkanpharma Troyan AD

1 Krayrechna Str.

Troyan 5600

Bulgaria

or

H2 Pharma

21 rue Jacques Tati, ZAC La Croix Bonnet

Bois d’Arcy 78390

France

This medicine is authorized in the Member States of the European Economic Area under the following names:

Belgium Desloratadine EG 0.5mg/ml drank

Denmark Desloratadin STADA

Finland Desloratadin STADA

Germany Desloratadin STADA 0.5 mg/ml Lösung zum Einnehmen

Hungary Desloratadine STADA

Luxembourg Desloratadine EG 0.5mg/ml soluzione buvable

Netherlands Desloratadine CF 0.5 mg/ml, drank

Portugal Desloratadina Ciclum

Spain Desloratadina STADA 0.5 mg/ml solución oral EFG

Date of last revision of this leaflet:November 2022

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION

Discuss questions about DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION?
DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION?
The active ingredient in DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION is desloratadine. This information helps identify medicines with the same composition but different brand names.
How much does DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION cost in pharmacies?
The average pharmacy price for DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION is around 3.98 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION?
DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION is manufactured by Laboratorio Stada S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DESLORATADINE STADA 0.5 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (desloratadine) include AERIUS 0.5 mg/ml ORAL SOLUTION, AERIUS 5 mg ORALLY DISINTEGRATING TABLETS, AERIUS 5 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media